search
Back to results

Does Reinforcement of the Staple Line in Left Pancreatectomy Reduce the Rate of Pancreatic Fistula?

Primary Purpose

Post Operative Pancreatic Fistula

Status
Unknown status
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Surgisis (C-SLRA-ECH60) made by COOK Medical
Sponsored by
Karolinska University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Post Operative Pancreatic Fistula focused on measuring Left sided pancreatic resections, Distal pancreatic resections, Reinforced staple line, Post operative pancreatic fistula

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Every patient eligible for pancreatic tail resection.

Exclusion Criteria:

  • Not able to read Swedish.
  • Not able to understand or accept the concept.

Sites / Locations

  • Dep of Surgical Gastroenterology, Karolinska University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Surgisis reinforcement of staple line

No reinforcement of staple line

Arm Description

The stapler used to divide the pancreas is reinforced with Surgisis (COOK Medical).

The stapler used to divide the pancreas is not reinforced with any material

Outcomes

Primary Outcome Measures

Post operative pancreatic fistula (POPF), Y/N
Pancreatic amylase concentration in any post operative drains. Fistula is diagnosed if pancreatic amylase > 3 times the upper normal limit of pancreatic amylase in plasma on post operative day 3 or later

Secondary Outcome Measures

POPF healing time
Time from diagnosis to healed pancreatic fistula
POPF grade according to International Study Group of Pancreatic Fistula (ISGPF) grade A/B/C
Worst POPF grade registered during the observation period.
Blood chemistry
During the first 7 post operative days each participant will have daily measurements taken from blood samples regarding C-reactive protein, white blood count, pancreatic plasma amylase and from drain fluid regarding pancreas amylase. The participants daily drain volume will also be measured.
Morbidity
According to Clavien scoring
Mortality
Hospital stay
Number of days

Full Information

First Posted
May 21, 2014
Last Updated
March 31, 2015
Sponsor
Karolinska University Hospital
Collaborators
Sahlgren´s University Hospital, Lund University Hospital, University Hospital, Linkoeping, Norrlands University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02149446
Brief Title
Does Reinforcement of the Staple Line in Left Pancreatectomy Reduce the Rate of Pancreatic Fistula?
Official Title
Pancreas Fistula After Distal Pancreatic Resection: Prevention and Treatment in a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2015
Overall Recruitment Status
Unknown status
Study Start Date
April 2014 (undefined)
Primary Completion Date
November 2016 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital
Collaborators
Sahlgren´s University Hospital, Lund University Hospital, University Hospital, Linkoeping, Norrlands University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Dividing pancreas when performing left-sided resections opens the risk for leakage from the divided end of the pancreas. Pancreatic juices could have a severe effect on surrounding abdominal tissues with abscess formation producing systemic inflammation and potential lethal bleeding. Studies have shown that reinforcement of the staple line when dividing pancreas could reduce the risk of leakage. Surgisis (COOK Medical) a product already in use for staple line reinforcement in gastric and lung surgery could be used as a reinforcement when stapling pancreas in left sided resections. In a prospective randomized trial we want to compare Surgisis reinforcement to no reinforcement of stapled division in left sided pancreatic resections. Primary outcome is pancreatic fistula yes/no.
Detailed Description
Resection of the distal pancreas is often done due to a localized tumor in the body or tail of the pancreas. During later years the mortality after pancreatic resections have been reduced but there still is a substantial risk of severe complications mainly due to leakage from the pancreatic division line which could lead to suffering, longer hospital stay, higher costs and sometimes death. Leakage from a tail resection is probably more common than thought of before. Frequencies of above 30% and even up to 60% have been reported. The use of somatostatin to reduce the production of pancreatic juice or comparison between stapled division, suturing of the remaining part of the cut pancreas or covering it with glue or available surrounding tissue have not showed significant superiority for any of these methods except for a positive trend regarding the stapling technique. Staple line reinforcement with resorbable mesh has in some studies showed a both negative and positive effect on pancreatic fistula frequency. These studies have been small and non-randomized. A larger randomized single blinded study by Hamilton et al on the other hand showed a significant positive effect on pancreatic fistula frequency after distal pancreatic resection using an absorbable reinforcement device put on the stapler, when only regarding type B and C fistulas as defined by the ISGPF (International Study Group on Pancreatic Fistula) pancreatic leak grading system. Although all these endeavors the problem of pancreatic fistulas remain and therefore all these operations are concluded with the deposit of one or more drains to the area of the cut pancreas. There is therefore of importance to continue the work of reducing complications in high risk pancreatic surgery using scientific procedures of high quality as in blinded randomized controlled trials (RCT). The use of reinforced stapling techniques has been used in lung surgery and bariatric surgery to reduce air leakage and strengthen anastomoses. The material used is processed submucosa from the small bowel of the pig, produced by COOK© Medical to fit endoscopic staplers from Ethicon© or Covidien©. After the promising result from Hamilton et al we plan to study if the reinforcement made by COOK© could reduce the frequency of pancreatic fistula after stapled distal pancreatic surgery in a single blinded RCT.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post Operative Pancreatic Fistula
Keywords
Left sided pancreatic resections, Distal pancreatic resections, Reinforced staple line, Post operative pancreatic fistula

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Surgisis reinforcement of staple line
Arm Type
Experimental
Arm Description
The stapler used to divide the pancreas is reinforced with Surgisis (COOK Medical).
Arm Title
No reinforcement of staple line
Arm Type
No Intervention
Arm Description
The stapler used to divide the pancreas is not reinforced with any material
Intervention Type
Device
Intervention Name(s)
Surgisis (C-SLRA-ECH60) made by COOK Medical
Other Intervention Name(s)
Surgisis reinforcement of staple line
Intervention Description
Surgisis is extracellular matrix collagen made of the submucosal layer of pigs intestines. Surgisis is gradually remodeled, leaving behind organized tissue
Primary Outcome Measure Information:
Title
Post operative pancreatic fistula (POPF), Y/N
Description
Pancreatic amylase concentration in any post operative drains. Fistula is diagnosed if pancreatic amylase > 3 times the upper normal limit of pancreatic amylase in plasma on post operative day 3 or later
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Secondary Outcome Measure Information:
Title
POPF healing time
Description
Time from diagnosis to healed pancreatic fistula
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
POPF grade according to International Study Group of Pancreatic Fistula (ISGPF) grade A/B/C
Description
Worst POPF grade registered during the observation period.
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Title
Blood chemistry
Description
During the first 7 post operative days each participant will have daily measurements taken from blood samples regarding C-reactive protein, white blood count, pancreatic plasma amylase and from drain fluid regarding pancreas amylase. The participants daily drain volume will also be measured.
Time Frame
The first 7 days after operation
Title
Morbidity
Description
According to Clavien scoring
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Title
Mortality
Time Frame
< 90 days after the operation
Title
Hospital stay
Description
Number of days
Time Frame
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Every patient eligible for pancreatic tail resection. Exclusion Criteria: Not able to read Swedish. Not able to understand or accept the concept.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John Blomberg, MD, PhD
Email
john.blomberg@karolinska.se
First Name & Middle Initial & Last Name or Official Title & Degree
Marco Del Chiaro, MD, PhD
Email
marco.del.chiaro@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Blomberg, MD, PhD
Organizational Affiliation
Dep of Surgical Gastoenterology, Karolinska University Hospital, Stockholm, Sweden
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dep of Surgical Gastroenterology, Karolinska University Hospital
City
Stockholm
ZIP/Postal Code
SE-141 86
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John Blomberg, MD, PhD

12. IPD Sharing Statement

Citations:
PubMed Identifier
33793753
Citation
Wennerblom J, Ateeb Z, Jonsson C, Bjornsson B, Tingstedt B, Williamsson C, Sandstrom P, Ansorge C, Blomberg J, Del Chiaro M. Reinforced versus standard stapler transection on postoperative pancreatic fistula in distal pancreatectomy: multicentre randomized clinical trial. Br J Surg. 2021 Apr 5;108(3):265-270. doi: 10.1093/bjs/znaa113.
Results Reference
derived

Learn more about this trial

Does Reinforcement of the Staple Line in Left Pancreatectomy Reduce the Rate of Pancreatic Fistula?

We'll reach out to this number within 24 hrs